ahlam1399
08-02-2016, 04:52 PM
Shire upgrades Baxalta cost savings after Q2 earnings beat
LONDON, Aug 2 (Reuters) - Drugmaker Shire upgraded its guidance for 2016 on Tuesday, after it hiked the predicted cost saving target for its $32 billion acquisition of rare disease ***** specialist... http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=FPPVNqIy0hY:1_y9i22r3So:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=FPPVNqIy0hY:1_y9i22r3So:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/FPPVNqIy0hY
LONDON, Aug 2 (Reuters) - Drugmaker Shire upgraded its guidance for 2016 on Tuesday, after it hiked the predicted cost saving target for its $32 billion acquisition of rare disease ***** specialist... http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=FPPVNqIy0hY:1_y9i22r3So:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=FPPVNqIy0hY:1_y9i22r3So:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=FPPVNqIy0hY:1_y9i22r3So:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/FPPVNqIy0hY